Biotech Investment Analyst, Drug Asset & Company Assessment
- Pay: $120 to $200 / hour
- Contract: Part time
- Who can apply: United States
- Posted Aug 5, 2026
In short
Mercor is hiring 5 remote Biotech Investment Analysts for a part-time pilot project paying 120 to 200 USD per hour. You will evaluate biotech assets and companies, making this an ideal role if you want flexible, high-paying remote work in the health sector.
What you will do
- Build and review rubrics for commercial drugs and drug programs
- Assess companies and drug assets, including clinical data and value drivers
- Evaluate investment theses and identify weak or missing assumptions
- Analyze a set of approximately 5 to 10 companies during the pilot
What you need to apply
- US-based biotech or healthcare investment analyst background
- Experience with biotech and pharma development programs
- Ability to assess drug assets and companies end-to-end
- At least 5 years of experience evaluating biotech companies or assets
Who can apply
This remote role is open exclusively to residents of the US.
My tip
At Simply Remotely, we advise you to clearly highlight your specific fund background and your experience assessing drug assets end-to-end to stand out.